Article Information
PubMed
Published By
History
- Received May 26, 2025
- Accepted September 9, 2025
- Published online December 23, 2025.
Article Versions
- previous version (October 22, 2025 - 00:09).
- You are viewing the most recent version of this article.
Copyright & Usage
Copyright: © 2025, The Authors This work is licensed under the Creative Commons Attribution-NonCommercial 4.0 International License.
Author Information
Funding
National Natural Science Foundation of China
82030082National Natural Science Foundation of China
82272845Natural Science Foundation of Shandong Province
ZR2023LZL001
This work was funded by the National Natural Science Foundation of China (Grant Nos. 82030082 and 82272845) and the Natural Science Foundation of Shandong Province (Grant No. ZR2023LZL001).
In this issue
Jump to section
- Article
- Upregulation of the COX-2/PGE2 axis impairs radioimmunotherapy efficacy
- COX-2 inhibition with celecoxib enhances radioimmunotherapy efficacy
- COX-2 expression and TCF1+CD8+ T cell infiltration as prognostic markers in radioimmunotherapy-naïve NSCLC
- Supporting Information
- Conflict of interest statement
- Author contributions
- Data availability statement
- References
- Figures & Data
- Info & Metrics
- References